Objective: As the practice of pharmacy continues to advance and involve nondispensing pharmacy services, point-of-care testing (POCT) has continued to demonstrate its usefulness as a tool and service in pharmacy. Of particular significance is the ability of POCT to assist clinical practice related to diabetes, cholesterol management, and anticoagulation. POCT can allow for certain laboratory results to be obtained within seconds to minutes, which can help direct care. Many components of POCT programs can involve pharmacy technicians to help enhance practice efficiency. The purpose of this review is to provide an overview of POCT devices commonly used in nondispensing pharmacy services and to describe the roles that pharmacy technicians may have in the POCT process. Data Sources: PubMed (1946-2014) was reviewed for relevant literature using terms such as “pharmacy technician” and “point of care testing.” Additionally, manufacturer information/websites of POCT products were reviewed for approval information and instructions for use. Study Selection and Data Extraction: Articles describing POCT completed in a pharmacy setting and/or roles of pharmacy technicians and related support staff in the POCT process were considered for inclusion. Data Synthesis: Several types of POCT devices for different uses common to the practice of pharmacy are reviewed. Additionally, strategies for collaboration between pharmacy technicians and pharmacists in the execution of a POCT program are described. Conclusion: Pharmacy technicians are well suited to participate in portions of the POCT process, and the involvement of pharmacy technicians may improve POCT efficiency.
StaffordLPetersonGMBereznickiLR. Clinical outcomes of a collaborative, home-based postdischarge warfarin management service. Ann Pharmacother. 2011;45:325-334.
2.
StaffordLPetersonGMBereznickiLRJacksonSL. A role for pharmacists in community-based post-discharge warfarin management: protocol for the “the role of the community pharmacy in post hospital management of patients initiated on warfarin” study. BMC Health Serv Res. 2011;11:16.
3.
GubbinsPOKlepserMEDering-AndersonAM. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy. J Am Pharm Assoc (2003). 2014;54:163-171.
GeertsAFDe KoningFHDe VooghtKMEgbertsACDe SmetPAvan SolingeWW. Feasibility of point-of-care creatinine testing in community pharmacy to monitor drug therapy in ambulatory elderly patients. J Clin Pharm Ther. 2013;38:416-422.
6.
FerreriSPGrecoAJMichaelsNM. Implementation of a pharmacogenomics services in a community pharmacy. J Am Pharm Assoc (2003). 2014;54:172-180.
7.
Council on Credentialing in Pharmacy; AlbaneseNPRouseMJ. Scope of contemporary pharmacy practice: roles, responsibilities, and functions of pharmacists and pharmacy technicians. J Am Pharm Assoc (2003). 2010;50:e35-e69.
8.
JohannigmanMJLeifheitMBellmanNPierceTMarriottABishopC. Medication therapy management and condition care services in a community-based employer setting. Am J Health Syst Pharm. 2010;67:1362-1367.
9.
BrightDRLengelAJPowersMF. Pharmacists’ perceptions of barriers to implementing medication therapy management and the role of pharmacy technicians in overcoming the barriers. J Pharm Technol. 2009;25:361-367.
10.
RodisJLThomasRA. Stepwise approach to developing point-of-care testing services in the community/ambulatory pharmacy setting. J Am Pharm Assoc (2003). 2006;46:594-604.
11.
American Diabetes Association. Standards of medical care in diabetes—2014. Diabetes Care. 2014;37:S14-S80.
PalombiLCBastianelliKStrattonT. Point-of-care screenings at the University of Minnesota: mechanism for civic engagement. J Am Pharm Assoc (2003). 2014;54:56-62.
